Background: Human Immunodeficiency viruses rely on host-encoded proteins to facilitate their replication. A previous genome-wide siRNA screening approach (Koenig et al., 2008) resulted in the identification of NLRX1 as a host cellular protein required for early stages of HIV-1 replication. NLRX1 is a member of the Nod-like Receptor family, which collectively play critical roles in innate immune responses. Thus, our data provide a compelling link between an innate immune signaling receptor, NLRX1, and HIV-1 replication. Methodology: HIV-1 luciferase reporter viruses pseudotyped by VSV-G and HIV-1 replication competent WT viruses were used to investigate the effect of silencing of NLRX1 on replication efficiency in various cell lines and primary cells. In addition, we assessed the infectivity levels of pseudotyped particles with amphotropic envelope using a pH-independant entry route and mapped the stage of viral inhibiton by real-time quantitative PCR. Effects on IRF3- dependant target gene expression were assessed by quantitative PCR and IFN ELISA. Results: We first validated NLRX1 as a factor required for early-stage HIV infection in various cell lines, including 293T, HeLa and more physiological relevant cells, THP1, Jurkat cells and primary macrophages. NLRX1-inhibition resulted in a failure to initiate reverse transcription and was independent of the viral entry route. NLRX1 was recently reported to act as a negative regulator of mitochondrial antiviral immunity, through binding and inhibition of MAVS, an essential mediator of the RIG-I and IRF3 antiviral response. Based on the hypothesis that the inhibition of NLRX1 may render the innate surveillance machinery competent to respond to HIV infection, we sought to determine the effects of NRLX1 depletion upon IRF3 target gene transcription. We observed that ISG54, IFN-β and IL-6 was robustly induced upon infection with HIV in NLRX1-depleted cells, but importantly, NLRX1 silencing did not induce these genes in the absence of HIV. Conclusions: These data suggest that restriction of HIV is not due to a generalized and persistent hyper-activation of an innate immune state in NLRX1- depleted cells. In conclusion, we demonstrate the requirement of NLRX1 for early HIV-1 replication. We are currently investigating the molecular basis of NLRX1 dependency in early stage HIV replication.